New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on: March 15,2024

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on:March 15,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on: February 01,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on:February 01,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on: April 01,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on:April 01,2024

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib

Updated on: May 08,2024

Differences in T cells' functional state determine resistance to cancer therapy

by Massachusetts Institute of TechnologyThe researchers took this image of a tumor using immunofluorescence, a technique that allows them to stain tissue sections with fluorescently-labeled antib

Updated on:May 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on: January 02,2024

Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on:January 02,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha

Updated on: January 30,2024

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha

Updated on:January 30,2024

What is a mammogram, and why are they important?

by Laurel KellyCredit: Pixabay/CC0 Public DomainBreast cancer accounts for 1 in 3 of all new cancers diagnosed in women in the U.S. each year, according to the American Cancer Society. It's estima

Updated on: January 04,2024

What is a mammogram, and why are they important?

by Laurel KellyCredit: Pixabay/CC0 Public DomainBreast cancer accounts for 1 in 3 of all new cancers diagnosed in women in the U.S. each year, according to the American Cancer Society. It's estima

Updated on:January 04,2024

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s

Updated on: May 06,2024

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s

Updated on:May 06,2024

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on: December 28,2023

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on:December 28,2023

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on: June 01,2024

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Updated on:June 01,2024